Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SciDerm was a premier specialty contract research organization (CRO) dedicated exclusively to the field of dermatology. Founded in 2001 by Dr. James Leyden, a world-renowned expert in dermatological research, the company provided comprehensive clinical development services, including strategic consulting, trial design, and site management. SciDerm was recognized for its deep therapeutic expertise and its ability to navigate the complex regulatory and clinical landscape of skin-related drug development. The company's specialized focus allowed it to support pharmaceutical and biotechnology firms in bringing innovative dermatological treatments to market. In December 2014, SciDerm was acquired by PPD (Pharmaceutical Product Development) to significantly bolster PPD's therapeutic depth and service offerings in the dermatology sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sciderm.